Sabrina Shue, MD
Interventional Pain Medicine · Harrison, NYNPI 1053530436
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,391 of the $6,693 with a category attached, or 80.5%. 33 manufacturers reported payments, led by Abbott at 25.9% of the total. Reporting peaked in 2019 at $3,092 and has fallen 88.8% since, to $347 in 2025.
Across 173 payments — averaging $38.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Nevro Corp.$902
- Boston Scientific$803
- Medtronic$529
- SPR Therapeutics, Inc$412
- Collegium Pharmaceutical, Inc.$262
- plus $2K from 27 others
What the payments were for
- Travel & lodging$1,30219%
- Food & beverage$5,39181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $1,735 |
| Nevro Corp. | 13 | $902 |
| Boston Scientific | 46 | $803 |
| Medtronic | 11 | $529 |
| SPR Therapeutics, Inc | 2 | $412 |
| Collegium Pharmaceutical, Inc. | 14 | $262 |
| AbbVie | 7 | $235 |
| Arbor Pharmaceuticals, Inc. | 11 | $206 |
| Acelrx Pharmaceuticals, Inc. | 6 | $205 |
| Si-bone, Inc. | 3 | $203 |
| Scilex Pharmaceuticals Inc. | 7 | $159 |
| Curonix LLC | 3 | $124 |
| Zyla Life Sciences, Inc. | 5 | $115 |
| Bioventus LLC | 3 | $102 |
| Relievant Medsystems, Inc. | 1 | $85 |
| Globus Medical | 2 | $63 |
| Pfizer | 3 | $62 |
| Johnson & Johnson | 2 | $56 |
| Almatica Pharma LLC | 2 | $51 |
| Avanos Medical | 2 | $50 |
| IBSA Pharma Inc. | 2 | $47 |
| Biotronik NRO, Inc. | 1 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Lundbeck LLC | 1 | $28 |
| Lenoss Medical Inc | 1 | $26 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Painteq LLC | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Amgen | 1 | $17 |
| Shionogi Inc | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Carolina Liquid Chemistries Corp | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$1,294
- SPRINT PNS System$334
- Omnia$257
- Senza Spinal Cord Stimulation System$253
- INTELLIS ADAPTIVESTIM$144
- iFuse Implant$138
- Senza$131
- DSUVIA$124
- O-ARM$120
How this compares
$6,693 in reported general payments places this provider in the 65th percentile of 132 interventional pain medicine providers in New York.
See all interventional pain medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 117 | $1,917 |
| Oxycodone Hcl | 70 | $1,095 |
| Gabapentin | 72 | $971 |
| Hydromorphone Hcl | 21 | $949 |
| Pregabalin | 41 | $787 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 50 | $676 |
| Cyclobenzaprine Hcl | 45 | $646 |
| Methadone Hcl | 28 | $294 |
| Ondansetron OdtOndansetron | 13 | $287 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 11 | $196 |
| Duloxetine Hcl | 28 | $168 |
| Tramadol Hcl | 42 | $160 |
| Tizanidine Hcl | 23 | $142 |
| Methylprednisolone | 19 | $129 |
| Baclofen | 14 | $114 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Harrison
- Corey HunterNew York$446K
- Neel MehtaNew York$432K
- Hemant KaliaRochester$179K
- Martin FerrilloAlbany$164K
- George ChaseKew Gardens$102K
- Kimberly SackheimNew York$102K
- Suelane OuroNew York$68K
- Gerard DegregorisNew York$49K
- Jafar SiddiquiWilliamsville$45K
- Alexander WeingartenSyosset$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.